Jason G D Gall

Summary

Affiliation: GenVec Inc
Country: USA

Publications

  1. pmc Aerosolized adenovirus-vectored vaccine as an alternative vaccine delivery method
    Chad J Roy
    Infectious Disease Aerobiology, Division of Microbiology, Tulane National Primate Research Center, Covington, LA 70447, USA
    Respir Res 12:153. 2011
  2. pmc Characterization of human adenovirus 35 and derivation of complex vectors
    Duncan McVey
    Department of Research, GenVec, Inc, Gaithersburg, MD 20874, USA
    Virol J 7:276. 2010
  3. ncbi request reprint Rescue and production of vaccine and therapeutic adenovirus vectors expressing inhibitory transgenes
    Jason G D Gall
    GenVec, Inc 65 West Watkins Mill Rd, Gaithersburg MD 20878, USA
    Mol Biotechnol 35:263-73. 2007
  4. pmc Potent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vaccine vector based on rare human serotype 28
    Christoph A Kahl
    GenVec, Inc, 65 West Watkins Mill Road, Gaithersburg, MD 20878, USA
    Vaccine 28:5691-702. 2010

Collaborators

  • Chad J Roy
  • Christoph A Kahl
  • Duncan McVey
  • C Richter King
  • Alida Ault
  • Srinivas S Rao
  • Chih Jen Wei
  • Satheesh K Sivasubramani
  • J Patrick Gorres
  • Mario Roederer
  • Hanne Andersen
  • Christopher D Reiter
  • Mohammed Zuber
  • Suja Hiriyanna
  • Ping Chen
  • Megan Fultz
  • Gary J Nabel
  • Jessica Bonnell
  • Cassandra Nyberg-Hoffman
  • Douglas E Brough
  • Damodar Ettyreddy

Detail Information

Publications4

  1. pmc Aerosolized adenovirus-vectored vaccine as an alternative vaccine delivery method
    Chad J Roy
    Infectious Disease Aerobiology, Division of Microbiology, Tulane National Primate Research Center, Covington, LA 70447, USA
    Respir Res 12:153. 2011
    ..Overall, aerosol delivery offers comparable protection to intramuscular injection, and represents an attractive vaccine delivery method for broad-based immunization campaigns...
  2. pmc Characterization of human adenovirus 35 and derivation of complex vectors
    Duncan McVey
    Department of Research, GenVec, Inc, Gaithersburg, MD 20874, USA
    Virol J 7:276. 2010
    ..The structure of the viral genome and life cycle of Ad35 differs from the better characterized Ad5 and these differences require differences in the strategies for the generation of vectors for gene delivery...
  3. ncbi request reprint Rescue and production of vaccine and therapeutic adenovirus vectors expressing inhibitory transgenes
    Jason G D Gall
    GenVec, Inc 65 West Watkins Mill Rd, Gaithersburg MD 20878, USA
    Mol Biotechnol 35:263-73. 2007
    ..The gene regulation system is a significant advancement for the development of adenovirus vectors for vaccine and other gene transfer applications...
  4. pmc Potent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vaccine vector based on rare human serotype 28
    Christoph A Kahl
    GenVec, Inc, 65 West Watkins Mill Road, Gaithersburg, MD 20878, USA
    Vaccine 28:5691-702. 2010
    ..The seroprevalence of Ad28 was confirmed to be <10% in the United States. Together, this shows that a rare human serotype-based vector can elicit strong immune responses, which was not predicted by in vitro results...